Principal Financial Group’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $40.3M | Buy |
239,193
+1,032
| +0.4% | +$153K | 0.02% | 605 |
|
|
2026
Q1 | $31.4M | Buy |
238,161
+11,784
| +5% | +$1.56M | 0.02% | 668 |
|
|
2025
Q4 | $32.1M | Sell |
226,377
-5,386
| -2% | -$780K | 0.02% | 632 |
|
|
2025
Q3 | $32.5M | Sell |
231,763
-11,967
| -5% | -$1.62M | 0.02% | 628 |
|
|
2025
Q2 | $30.6M | Sell |
243,730
-4,690
| -2% | -$538K | 0.02% | 633 |
|
|
2025
Q1 | $27.5M | Sell |
248,420
-4,049
| -2% | -$513K | 0.02% | 654 |
|
|
2024
Q4 | $34.5M | Sell |
252,469
-717
| -0.3% | -$88.7K | 0.02% | 586 |
|
|
2024
Q3 | $29.2M | Sell |
253,186
-120,576
| -32% | -$16.5M | 0.02% | 651 |
|
|
2024
Q2 | $51.5M | Sell |
373,762
-44,913
| -11% | -$6.16M | 0.03% | 451 |
|
|
2024
Q1 | $57.7M | Buy |
418,675
+430
| +0.1% | +$58.7K | 0.03% | 434 |
|
|
2023
Q4 | $55.1M | Buy |
418,245
+40,289
| +11% | +$4.64M | 0.04% | 410 |
|
|
2023
Q3 | $42.5M | Sell |
377,956
-5,978
| -2% | -$629K | 0.03% | 463 |
|
|
2023
Q2 | $36.2M | Sell |
383,934
-3,648
| -0.9% | -$356K | 0.02% | 546 |
|
|
2023
Q1 | $39.2M | Sell |
387,582
-13,082
| -3% | -$1.36M | 0.03% | 509 |
|
|
2022
Q4 | $47.9M | Buy |
400,664
+11,659
| +3% | +$1.37M | 0.04% | 425 |
|
|
2022
Q3 | $41.3M | Sell |
389,005
-3,502
| -0.9% | -$355K | 0.03% | 444 |
|
|
2022
Q2 | $38.3M | Buy |
392,507
+67,568
| +21% | +$6.24M | 0.03% | 505 |
|
|
2022
Q1 | $30.5M | Sell |
324,939
-3,520
| -1% | -$298K | 0.02% | 655 |
|
|
2021
Q4 | $28M | Sell |
328,459
-3,313
| -1% | -$305K | 0.02% | 725 |
|
|
2021
Q3 | $31.8M | Sell |
331,772
-1,967
| -0.6% | -$186K | 0.02% | 623 |
|
|
2021
Q2 | $32.5M | Buy |
333,739
+5,912
| +2% | +$567K | 0.02% | 633 |
|
|
2021
Q1 | $31.9M | Buy |
327,827
+316,575
| +2,813% | +$33.2M | 0.02% | 611 |
|
|
2020
Q4 | $1.08M | Sell |
11,252
-362
| -3% | -$35K | ﹤0.01% | 1929 |
|
|
2020
Q3 | $1.12M | Sell |
11,614
-2,072
| -15% | -$240K | ﹤0.01% | 1850 |
|
|
2020
Q2 | $1.67M | Buy |
13,686
+3,369
| +33% | +$372K | ﹤0.01% | 1734 |
|
|
2020
Q1 | $893K | Buy |
10,317
+400
| +4% | +$39.1K | ﹤0.01% | 1750 |
|
|
2019
Q4 | $1.07M | Sell |
9,917
-47,178
| -83% | -$4.94M | ﹤0.01% | 1823 |
|
|
2019
Q3 | $5.14M | Buy |
57,095
+2,381
| +4% | +$222K | ﹤0.01% | 1507 |
|
|
2019
Q2 | $4.62M | Buy |
54,714
+519
| +1% | +$42.6K | ﹤0.01% | 1553 |
|
|
2019
Q1 | $4.78M | Buy |
54,195
+10
| +0% | +$836 | ﹤0.01% | 1557 |
|
|
2018
Q4 | $3.87M | Sell |
54,185
-29,816
| -35% | -$2.86M | ﹤0.01% | 1588 |
|
|
2018
Q3 | $10.3M | Sell |
84,001
-8,082
| -9% | -$917K | 0.01% | 1306 |
|
|
2018
Q2 | $9.05M | Buy |
92,083
+13,127
| +17% | +$1.18M | 0.01% | 1363 |
|
|
2018
Q1 | $6.55M | Buy |
78,956
+1,234
| +2% | +$104K | 0.01% | 1461 |
|
|
2017
Q4 | $6.03M | Buy |
77,722
+882
| +1% | +$60.2K | 0.01% | 1499 |
|
|
2017
Q3 | $4.71M | Sell |
76,840
-839
| -1% | -$44.3K | ﹤0.01% | 1575 |
|
|
2017
Q2 | $3.57M | Buy |
77,679
+1,728
| +2% | +$83.8K | ﹤0.01% | 1644 |
|
|
2017
Q1 | $3.29M | Sell |
75,951
-194
| -0.3% | -$8.31K | ﹤0.01% | 1649 |
|
|
2016
Q4 | $2.95M | Buy |
76,145
+5,386
| +8% | +$244K | ﹤0.01% | 1653 |
|
|
2016
Q3 | $3.58M | Sell |
70,759
-82,682
| -54% | -$4.12M | ﹤0.01% | 1572 |
|
|
2016
Q2 | $6.97M | Sell |
153,441
-7,450
| -5% | -$343K | 0.01% | 1276 |
|
|
2016
Q1 | $6.36M | Buy |
160,891
+658
| +0.4% | +$26.1K | 0.01% | 1262 |
|
|
2015
Q4 | $9.06M | Buy |
160,233
+449
| +0.3% | +$22.8K | 0.01% | 1024 |
|
|
2015
Q3 | $6.36M | Buy |
159,784
+145,057
| +985% | +$7.01M | 0.01% | 1215 |
|
|
2015
Q2 | $703K | Buy |
14,727
+2,632
| +22% | +$112K | ﹤0.01% | 1822 |
|
|
2015
Q1 | $480K | Sell |
12,095
-154
| -1% | -$5.51K | ﹤0.01% | 1847 |
|
|
2014
Q4 | $274K | Sell |
12,249
-1,675
| -12% | -$31.7K | ﹤0.01% | 1953 |
|
|
2014
Q3 | $218K | Hold |
13,924
| – | – | ﹤0.01% | 2006 |
|
|
2014
Q2 | $207K | Sell |
13,924
-4,415
| -24% | -$62.3K | ﹤0.01% | 2080 |
|
|
2014
Q1 | $295K | Buy |
+18,339
| New | +$314K | ﹤0.01% | 1999 |
|
|
2013
Q4 | – | Sell |
-21,277
| Closed | -$241K | – | 2297 |
|
|
2013
Q3 | $241K | Sell |
21,277
-2,059
| -9% | -$28.3K | ﹤0.01% | 2037 |
|
|
2013
Q2 | $312K | Buy |
+23,336
| New | +$287K | ﹤0.01% | 1926 |
|
Other funds holding NBIX
Principal Financial Group's NBIX Position: Q2 2026 in Review
Principal Financial Group increased its Neurocrine Biosciences (NBIX) stake by 0.43% in Q2 2026, buying an estimated $153K and bringing the position to 239,193 shares worth $40.3M. The position accounts for 0.02% of the portfolio, ranked #605.
Principal Financial Group first reported a position in NBIX in Q2 2013 and has held it in 52 quarters since. The position peaked at $57.7M in Q1 2024. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.
- Principal Financial Group held 239,193 shares of Neurocrine Biosciences worth $40.3M as of Q2 2026.
- Principal Financial Group bought 1,032 Neurocrine Biosciences shares in Q2 2026, an estimated $153K.
- Neurocrine Biosciences made up 0.02% of Principal Financial Group's portfolio in Q2 2026, its #605 holding.
- Principal Financial Group first reported a position in Neurocrine Biosciences in Q2 2013 and has held it in 52 quarters since.
- Principal Financial Group's Neurocrine Biosciences position peaked at $57.7M in Q1 2024.
- 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.